Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001984737 | SCV002217472 | pathogenic | Wilson disease | 2022-09-23 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Pro863Glnfs*10) in the ATP7B gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ATP7B are known to be pathogenic (PMID: 10441329, 16283883). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with ATP7B-related conditions. ClinVar contains an entry for this variant (Variation ID: 1434876). For these reasons, this variant has been classified as Pathogenic. |
Baylor Genetics | RCV001984737 | SCV005053104 | likely pathogenic | Wilson disease | 2023-11-21 | criteria provided, single submitter | clinical testing | |
Gene |
RCV005241479 | SCV005889012 | pathogenic | not provided | 2024-09-13 | criteria provided, single submitter | clinical testing | Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); Has not been previously published as pathogenic or benign to our knowledge |